BioMmune, A 2016 TSX Venture Top 50 Company, Awarded Patent for Calcium Channel Monoclonal Antibodies
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/29/16 -- bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE: IMU) has been awarded its first patent for monoclonal antibodies that modulate voltage gated calcium …